NeoVentures Biotechnology Inc.
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$620,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeoVentures Biotechnology Inc. is a biotechnology company that provides aptamer discovery and validation services and develops proprietary aptamer-based diagnostic and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoVentures Biotechnology Inc. Comparables
Compare NeoVentures Biotechnology Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptagen, LLC | 89% | |
| Raptamer Therapeutics | 86% | |
| Novaptech | 84% | |
NeoVentures Biotechnology Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Series A | Mar 18, 2024 | ||||
| Grant | Apr 30, 2022 | ||||
| Grant | Jun 16, 2009 | ||||
| Grant | Aug 6, 2008 |
NeoVentures Biotechnology Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon Europe | Grant |
| Government of Canada | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 64% MoM.
- Jun 19, 2026
Monthly visitors increased 49% MoM.
NeoVentures Biotechnology Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeoVentures Biotechnology Inc.'s valuation, stock price, and market status.